Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
txYbYhpMe2kPhXsA